切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2016, Vol. 05 ›› Issue (04) : 254 -259. doi: 10.3877/cma.j.issn.2095-3232.2016.04.012

所属专题: 文献

临床研究

肝滤泡树突状细胞肉瘤一例并文献复习
江均良1, 何净明2, 黄泽坚2, 刘开睿2, 张磊2,()   
  1. 1. 510080 广州市白云区人民医院外一科
    2. 510120 广州,中山大学孙逸仙纪念医院肝胆外科
  • 收稿日期:2016-04-17 出版日期:2016-08-10
  • 通信作者: 张磊
  • 基金资助:
    广东省自然科学基金(S2012010009741); 广东省医学科研基金(A2015462)

Hepatic follicular dentritic cell sarcoma: report of one case and literature review

Junliang Jiang1, Jingming He2, Zejian Huang2, Kairui Liu2, Lei Zhang2,()   

  1. 1. Department I of Surgery, the People’s Hospital of Baiyun District of Guangzhou, Guangzhou 510080, China
    2. Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou 510120, China
  • Received:2016-04-17 Published:2016-08-10
  • Corresponding author: Lei Zhang
  • About author:
    Corresponding author: Zhang Lei, Email:
引用本文:

江均良, 何净明, 黄泽坚, 刘开睿, 张磊. 肝滤泡树突状细胞肉瘤一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2016, 05(04): 254-259.

Junliang Jiang, Jingming He, Zejian Huang, Kairui Liu, Lei Zhang. Hepatic follicular dentritic cell sarcoma: report of one case and literature review[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2016, 05(04): 254-259.

目的

探讨肝滤泡树突状细胞肉瘤(FDCS)的临床病理学特征及其诊治。

方法

回顾性分析2015年12月中山大学孙逸仙纪念医院收治的1例肝FDCS患者临床资料,并复习相关文献。患者已签署知情同意书,符合医学伦理学规定。患者男,年龄34岁,因体检发现肝左叶占位性病变10 d入院。无肝炎、肝硬化病史。体检:全身皮肤、巩膜无明显黄染,浅表淋巴结未触及肿大,肝脾肋下未触及,肝区无明显叩击痛。实验室检查:ALT 162 U/L、AST 74 U/L、GGT 148 U/L,AFP、CEA、CA19-9、癌抗原(CA)125、CA72-4正常。超声、CT、MRI检查示:肝左外叶占位性病变。入院诊断为原发性肝癌。

结果

患者入院3 d行腹腔镜左半肝切除术,术中见肿瘤位于肝左外叶,切面灰黄色。术后病理学检查示梭形细胞和卵圆细胞弥漫性增生,淋巴细胞、浆细胞、中性粒细胞及嗜酸性粒细胞浸润。免疫组化检测示:Vimentin(+)、CD21(+)、CD35(+)、CD23(+)、EBER(+),病理学诊断高分化肝FDCS。患者术后定期随访,截止投稿日期未见肿瘤复发。

结论

肝FDCS无特异性临床表现,确诊主要依靠病理学检查,免疫组化在鉴别诊断中有重要作用。治疗以手术切除为主。

Objective

To investigate the clinicopathological characteristics, diagnosis and treatment of hepatic follicular dendritic cell sarcoma (FDCS).

Methods

Clinical data of one case with hepatic FDCS who was admitted to Sun Yat-sen Memorial Hospital of Sun Yat-sen University were retrospectively analyzed and relevant literature was reviewed. The informed consents of the patient were obtained and the local ethical committee approval was received. The male patient, aged 34 years old, was admitted to hospital due to an occupying lesion in the left lobe of liver found by physical examination for 10 d. The patient had no history of hepatitis or liver cirrhosis. No evident yellow skin or sclera was found by physical examination. No palpable superficial lymphadenopathy was found. The liver and spleen were not palpated under the ribs. No apparent percussion pain was found in the liver area. Laboratory test revealed the levels of alanine aminotransferase (ALT) was 162 U/L, aspartate aminotransferase (AST) was 74 U/L and gamma-glutamyl transferase (GGT) was 148 U/L. And the alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), cancer antigen (CA) 125, and CA72-4 were within the normal range. An occupying lesion in the left lateral lobe of liver were found by Ultrasound, computed tomography (CT) and magnetic resonance imaging (MRI). The admission diagnosis was primary liver cancer.

Results

Larparoscopic left hemihepatectomy was performed on the patient at 3 d after admission. A tumor with grayish yellow section was found in the left lateral lobe of liver during the operation. Postoperative pathological examination revealed diffuse proliferation of spindle and oval cells, and infiltration of lymphocyte, plasma cell, neutrophil and eosinophil. Immunohistochemical test revealed Vimentin(+), cluster of differentiation (CD)21(+), CD35(+), CD23(+) and EBER(+). The pathological diagnosis was highly-differentiated hepatic FDCS. The patient received a regular follow-up after operation and no tumor recurrence was observed until the submission date.

Conclusions

Hepatic FDCS has no specific clinical manifestation. The diagnosis depends on pathological examination. Immunohistochemical test plays an important role in the differential diagnosis. And the mainly treatment was surgical resection.

图1 一例肝滤泡树突状细胞肉瘤患者影像学表现
图2 肝滤泡树突状细胞肉瘤光镜下病理学表现
表1 肝滤泡树突状细胞肉瘤病例报道情况
研究者 发表年份 性别 年龄(岁) 所在肝部位 症状 治疗方法 术后随访结果
Shek等[3] 1996 35 右叶 上腹部不适、发热、 右半肝切除术 30个月肝右叶复发,60个月后腹膜及升结
? ? ? ? ? 消瘦 ? 肠复发,95个月死于多发转移
Selves等[4] 1996 68 左叶 烦躁不安、消瘦 化疗+肝切除术 2年半内无复发
Shek等[5] 1998 37 右叶 烦躁不安、消瘦 右半肝切除术 42个月内无复发
Cheuk等[6] 2001 19 肝脏 右上腹痛、腹部进行性 手术切除 40个月内无复发
? ? ? ? ? 增大包块、消瘦 ? ?
? ? 31 右叶 腹部不适、消瘦 右半肝切除术 60个月内无复发
? 40 左叶 上腹痛、消瘦 左半肝切除术 108个月出现腹腔内复发
? 49 肝脏 无症状,超声发现 手术切除 9个月内无复发
? 56 右叶 胃肠不适 右半肝切除术 15个月肝内复发,56个月仍存活
Torres等[7] 2005 82 右叶 乏力、发热、消瘦 右半肝切除术 18个月内无复发
Bai等[8] 2006 30 右叶 无症状,超声发现 右半肝切除术 1年内无复发
王华明等[9] 2006 33 左叶 上腹部疼痛,乙肝病史 左半肝切除术 8个月复发
刘军等[10] 2009 75 左叶 右上腹疼痛、高热 肝段切除术 12个月内无复发
黄海建等[11] 2010 54 左叶 偶然发现,乙肝病史 手术切除 35个月内无复发
? ? 45 左叶 左上腹疼痛 手术切除 6个月内无复发
? ? 40 右叶 皮肤瘀斑、面色苍白 手术切除+化疗 2个月后脾脏复发转移,4个月后仍存活
肖晓岚等[12] 2010 34 左叶 偶然发现 肝左外叶切除术+ 术后于肝脏、胰腺、腹膜、腹壁多处复发、转
? ? ? ? ? ? 化疗 移,行化疗、微波消融治疗等,带瘤生存
Martins等[13] 2011 53 左叶 黄疸、上腹痛、贫血、 左半肝切除术 6个月内无复发
? ? ? ? ? 发热,乙肝病史 ? ?
Shinagare等[14] 2011 56 右叶 右上腹痛 新辅助化疗、TACE+ 1年内无复发
? ? ? ? ? ? 右半肝切除术 ?
陈定宝等[15] 2012 46 左叶 偶然发现,乙肝病史 肝癌切除术 2个月肝脏复发行栓塞术,后无复发
Li等[16] 2014 38 左叶 乏力、厌食 左半肝切除术 11个月内无复发
? ? 42 肝脏 腹部疼痛 局部切除术 36个月内无复发
? 39 肝脏 偶然发现 肝叶切除术,复发后行 12个月复发,行再次治疗后84个月内
? ? ? ? 化疗+肿物局部切除 无复发
张先舟等[17] 2015 49 左叶 上腹部疼痛、腹部肿块 左半肝切除术 2~10年内肝脏、腹腔、胸壁等多处复发、
? ? ? ? ? ? ? 转移,切除后11年内仍存活
本例 2016 34 左叶 偶然发现 左半肝切除术 2个月内无复发征象
表2 肝滤泡树突状细胞肉瘤影像学特点
研究者 发表年份 性别 年龄(岁) 超声 CT MRI
Selves等[4] 1996 68 - 肝左叶单一边界清晰的圆形肿物,直径约11 cm,中间有低密度影 -
? ? ? ?
Torres等[7] 2005 82 - 肝右叶单一边界清晰的不规则肿物,大小约15 cm×10 cm,内可见一低密度坏死区 -
? ? ? ?
刘军等[10] 2009 75 肝左叶5.0 cm×3.4 cm低回声结节,中心呈囊样 肝左叶低密度灶,边界模糊,增强中心区未见明显强化 肝左叶类圆形信号,T1WI呈混杂低信号,T2WI以高信号为主,边界清晰
? ? ? ?
黄海建等[11] 2010 54 - - 11.0 cm边界清晰的高密度信号影
? ? 45 - - 16.5 cm边界清晰的多结节状高密度信号影
? ? 40 - - 18.5 cm边界不清的高密度信号影,累及周围组织
? ?
Shinagare等[14] 2011 56 - 冠状面可见直径11 cm的低密度肿物 -
? ? ? ?
Martins等[13] 2011 53 - - 11.5 cm分叶状左半肝肿物,中心可见钙化
陈定宝等[15] 2012 46 肝左叶见一1.8 cm×1.5 cm低回声影,边界欠清 - -
? ? ? ?
本例 2016 34 肝左外叶内一肿物,类圆形,内部低回声,分布不均质,边缘清楚,肝内管道结构受压移位 肝左外叶见椭圆形稍低密度灶,边界清,大小7.5 cm×6.7 cm×5.7 cm,增强扫描动脉期呈欠均匀显著强化,三期增强扫描呈快进快退强化方式 肝左外叶类圆形肿块,边界清晰,T1WI低信号,T2WI低压脂序列不均匀高信号,增强扫描早期病灶可见不均匀的明显强化,晚期强化减弱
? ? ? ?
? ? ? ?
[1]
Youens KE, Waugh MS. Extranodal follicular dendritic cell sarcoma[J]. Arch Pathol Lab Med, 2008, 132(10): 1683-1687.
[2]
Granados R, Aramburu JA, Rodríguez JM, et al. Cytopathology of a primary follicular dendritic cell sarcoma of the liver of the inflammatory pseudotumor-like type[J]. Diagn Cytopathol, 2008, 36(1):42-46.
[3]
Shek TW, Ho FC, Ng IO, et al. Follicular dendritic cell tumor of the liver. Evidence for an Epstein-Barr virus-related clonal proliferation of follicular dendritic cells[J]. Am J Surg Pathol, 1996, 20(3): 313-324.
[4]
Selves J, Meggetto F, Brousset P, et al. Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus[J]. Am J Surg Pathol, 1996, 20(6): 747-753.
[5]
Shek TW, Liu CL, Peh WC, et al. Intra-abdominal follicular dendritic cell tumour: a rare tumour in need of recognition[J]. Histopathology, 1998, 33(5): 465-470.
[6]
Cheuk W, Chan JK, Shek TW, et al. Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association[J]. Am J Surg Pathol, 2001, 25(6): 721-731.
[7]
Torres U, Hawkins WG, Antonescu CR, et al. Hepatic follicular dendritic cell sarcoma without Epstein-Barr virus expression[J]. Arch Pathol Lab Med, 2005, 129(11): 1480-1483.
[8]
Bai LY, Kwang WK, Chiang IP, et al. Follicular dendritic cell tumor of the liver associated with Epstein-Barr virus[J]. Jpn J Clin Oncol, 2006, 36(4): 249-253.
[9]
王华明,赵景民,李勇武,等.肝脏滤泡树突状细胞肉瘤1例报告并文献复习[J].中国误诊学杂志,2006, 24(6): 4718-4720.
[10]
刘军,张忠涛,李建设,等.肝滤泡树突细胞肉瘤1例报告并文献复习[J].中国实用外科杂志,2009, 29(5): 421-424.
[11]
黄海建,余英豪,郑智勇.肝脏滤泡树突状细胞肉瘤临床病理特征[J]. 世界华人消化杂志,2010, 18(33): 3520-3526.
[12]
肖晓岚,朱芳恒,王辅林.肝脏滤泡树突状细胞肉瘤的临床病理分析[J].中国现代医学杂志,2010, 20(11): 1656-1660.
[13]
Martins PN, Reddy S, Martins AB, et al. Follicular dendritic cell sarcoma of the liver: unusual presentation of a rare tumor and literature review[J]. Hepatobiliary Pancreat Dis Int, 2011, 10(4): 443-445.
[14]
Shinagare AB, Ramaiya NH, Jagannathan JP, et al. Primary follicular dendritic cell sarcoma of liver treated with cyclophosphamide, doxorubicin, vincristine, and prednisone regimen and surgery[J]. J Clin Oncol, 2011, 29(35): e849-851.
[15]
陈定宝,宋秋静,沈丹华.肝树突细胞肿瘤2例报道并文献复习[J].临床与实验病理学杂志,2012, 28(12): 1386-1390.
[16]
Li XQ, Cheuk W, Lam PW, et al. Inflammatory pseudotumor-like follicular dendritic cell tumor of liver and spleen: granulomatous and eosinophil-rich variants mimicking inflammatory or infective lesions[J]. Am J Surg Pathol, 2014, 38(5): 646-653.
[17]
张先舟,聂常富,韩风,等.肝滤泡树突状细胞肉瘤一例并文献复习[J/CD].中华肝脏外科手术学电子杂志,2015, 4(2): 109-112.
[18]
Li J, Geng ZJ, Xie CM, et al. Computer tomography imaging findings of abdominal follicular dendritic cell sarcoma: a report of 5 cases[J]. Medicine, 2016, 95(1): e2404.
[19]
Kang TW, Lee SJ, Song HJ. Follicular dendritic cell sarcoma of the abdomen: the imaging findings[J]. Korean J Radiol, 2010, 11(2): 239-243.
[20]
张正祥,程静,石群立,等.滤泡树突状细胞肉瘤的临床病理观察[J].中华病理学杂志,2008, 37(6): 395-399.
[21]
Grogg KL, Macon WR, Kurtin PJ, et al. A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor[J]. Mod Pathol, 2005, 18(2):260-266.
[22]
Jiang L, Tan H, Wang W, et al. A rare case of follicular dendritic cell sarcoma involving multiple bones[J]. Clin Nucl Med, 2013, 38(7): 582-585.
[23]
董辉,丛文玲,朱忠政,等.肝细胞癌与肝内胆管癌的免疫组化诊断[J].中华肿瘤杂志,2008, 30(9): 702-705.
[24]
Wang L, Cheng H, Li J, et al. Extranodal follicular dendritic cell sarcoma of the soft palate: a case report[J]. Int J Clin Exp Pathol, 2014, 7(12): 8962-8966.
[25]
Tsunemine H, Akasaka H, Kusama T, et al. Hepatic follicular dendritic cell sarcoma favorably controlled by transcatheter arterial chemoembolization[J]. Intern Med, 2010, 49(24): 2703-2707.
[26]
Conry RM. Response of follicular dendritic cell sarcoma to gemcitabine and docetaxel: report of two cases and literature review[J]. Clin Sarcoma Res, 2014(4): 6.
[1] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[2] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[3] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[4] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[5] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[6] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[7] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[8] 李友, 唐林峰, 杜伟伟, 刘海亮, 余新水, 沈佳宇, 巨积辉. 皮瓣联合掌长肌腱折叠单排三点式固定治疗指背侧创面伴锤状指畸形的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 485-490.
[9] 刘敏, 唐恩溢, 刘喆, 葛苏蒙, 刘梅, 孙国文. 计算机导航技术在口腔颌面部微小异物取出手术中的应用[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 375-379.
[10] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[11] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[12] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[13] 陈宗杰, 胡添松. 肝外伤破裂患者治疗后胆漏发生影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 836-840.
[14] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[15] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?